Low-molecular-weight heparins in the treatment of venous thromboembolism.

Curr Control Trials Cardiovasc Med · 2000 · PMC59610 · PMID 11714421

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The event rates of recurrent venous thromboembolism and major bleeding did not reach statistical significance and therefore it was concluded that the LMWH enoxaparine was not inferior to unfractionated heparin in the treatment of deep venous thrombosis.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.